RCM
GCVRZ

Royal Capital Management’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Royal Capital Management’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-1,870,269
Closed -$3.55M – 26
2013
Q2 		$3.55M Buy
+1,870,269
New +$3.29M 1.23% 21

Other funds holding GCVRZ

ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
DI
Dalton Investments Las Vegas, Nevada $111M AUM 7.89% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $7.65B AUM 13.87% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
MCM
Mason Capital Management New York $607M AUM 1.77% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
AAA
Alpine Associates Advisors Englewood Cliffs, New Jersey $158M AUM 48.85% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Royal Capital Management's GCVRZ Position: Q3 2013 in Review

Royal Capital Management sold out of Sanofi Contingent Value Rights (GCVRZ) in Q3 2013, closing a stake of 1,870,269 shares — an estimated $3.55M sold.

Royal Capital Management first reported a position in GCVRZ in Q2 2013 and held it in 1 quarter. The position peaked at $3.55M in Q2 2013. 136 funds tracked by Wall St. Rank hold GCVRZ as of Q3 2013.

  • Royal Capital Management reported no remaining Sanofi Contingent Value Rights position as of Q3 2013 after selling out during the quarter.
  • Royal Capital Management sold 1,870,269 Sanofi Contingent Value Rights shares in Q3 2013, an estimated $3.55M.
  • Royal Capital Management first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 1 quarter.
  • Royal Capital Management's Sanofi Contingent Value Rights position peaked at $3.55M in Q2 2013.
  • 136 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q3 2013.

Based on Royal Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.